Sanofi is jet­ti­son­ing its in­fec­tious dis­ease unit to Evotec — hand­ing over cash, staff and a pipeline

8 years ago
R&D
Pharma

The un­der­dog cham­pi­on of Roche’s huge pRED group is out. John Reed is com­ing home to Amer­i­ca

8 years ago
People
R&D

Dou­bling down on the Keytru­da fran­chise, Mer­ck pays $300M and promis­es $5B-plus to part­ner with Ei­sai on its bud­ding ...

8 years ago
Pharma

Pfiz­er breaks off a 5-year, $635M col­lab­o­ra­tion deal with Cy­tomX, with noth­ing to show for it

8 years ago
Pharma

'Rigged' pay­ment schemes by in­sur­ers and PBMs is block­ing the switch to biosim­i­lars, says FDA com­mis­sion­er

8 years ago
Pharma

#MeToo: ex-Sanofi em­ploy­ee gets un­fair dis­missal law­suit tossed, Ap­tose inks $125M BET in­hibitor deal

8 years ago
News Briefing

De­flat­ing R&D claims, pros­e­cu­tors say an im­pa­tient Mar­tin Shkre­li con­duct­ed bo­gus drug study in Cyprus

8 years ago
People

No­var­tis joins forces with LA tech com­pa­ny Sci­ence 37 to launch vir­tu­al clin­i­cal tri­als

8 years ago
R&D

Flanked by ri­vals and skep­tics, Es­pe­ri­on flips pos­i­tive da­ta on first PhI­II for a po­ten­tial­ly game-chang­ing ...

8 years ago
R&D
Pharma

SF tech start­up Atom­wise gets $45M for AI-pow­ered drug de­sign soft­ware

8 years ago
Financing
Startups

As killer virus out­breaks hit un­prece­dent­ed lev­els, non­prof­it hands $37.5M to Themis to tack­le Las­sa/MERS vac­cines

8 years ago
R&D

Ox­ford Vacmedix moves can­cer vac­cines for­ward with $12.5M from South Ko­rea, Chi­na

8 years ago
Financing
China

Meta­vant makes a de­but: Vivek Ra­maswamy launch­es biotech #7 and builds a di­a­betes pipeline with Lig­and deal

8 years ago
Financing
Pharma

Made in Chi­na: TaiMed wins FDA OK for a 'break­through' HIV ther­a­py for drug-re­sis­tant pa­tients

8 years ago
Pharma

Jakobovits abrupt­ly ex­its Adicet; Stan­ford re­searchers un­cov­er mech­a­nis­tic de­tails of ALS us­ing CRISPR

8 years ago
News Briefing

Faster, more con­ve­nient Op­di­vo dos­ing sched­ules gives Bris­tol-My­ers added edge in bat­tle of the PD-1 block­busters ...

8 years ago
Pharma

View­Point Ther­a­peu­tics gets $35M to ad­vance non-sur­gi­cal al­ter­na­tive for cataracts, pres­by­opia

8 years ago
Financing

Af­ter bag­ging Shire’s cell ther­a­py castoff, Cal­adrius stock climbs

8 years ago
Pharma

Search­ing for HIV cure, Gilead­'s new 'shock and kil­l' com­bo swats back lethal virus in mon­keys

8 years ago
Discovery

Qui­et and con­fi­den­tial IPO reg­is­tra­tion? Who needs it. Au­to­lus shouts about its next big raise

8 years ago
Financing

Cam­bridge star Ma­gen­ta teams up with Hei­del­berg on bone mar­row R&D pact that in­cludes $334M in po­ten­tial mile­stones

8 years ago
R&D
Pharma

Judg­ment day is com­ing: Fed­er­al judge or­ders Mar­tin Shkre­li to for­feit a small for­tune fol­low­ing felony con­vic­tions

8 years ago
People

Glob­al CRO Parex­el woos out­sourc­ing vet­er­an Jamie Mac­don­ald to the helm

8 years ago
People
Outsourcing

Ar­cus to raise $99M IPO; Van­da wants mar­ket­ing ap­proval for jet lag

8 years ago
News Briefing
First page Previous page 1045104610471048104910501051 Next page Last page
A service from the Financial Times